Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain
Clinical trial NCT02508337 · COMPLETED
Trial details
- NCT number
- NCT02508337
- Sponsor
- Xigen SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-01-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.